CCDC85C and hepatocellular carcinoma: In addition, KLF7 promoted HCC cell proliferation, invasion, cell cycle and blocked cell apoptosis by enhancing Ccdc85c-medicated β-catenin pathway, which might be a worthwhile therapeutic target for HCC.